USANA Health Sciences, Inc.
USNA
$20.03
$0.231.16%
NYSE
| 09/27/2025 | 06/28/2025 | 03/29/2025 | 12/28/2024 | 09/28/2024 | |
|---|---|---|---|---|---|
| Revenue | 912.67M | 899.22M | 876.24M | 854.50M | 861.97M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 912.67M | 899.22M | 876.24M | 854.50M | 861.97M |
| Cost of Revenue | 190.00M | 180.44M | 170.59M | 161.21M | 164.98M |
| Gross Profit | 722.67M | 718.78M | 705.65M | 693.29M | 697.00M |
| SG&A Expenses | 680.85M | 662.58M | 648.33M | 626.97M | 614.66M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 870.85M | 843.02M | 818.92M | 788.18M | 779.64M |
| Operating Income | 41.82M | 56.20M | 57.32M | 66.32M | 82.33M |
| Income Before Tax | 47.78M | 64.59M | 65.98M | 76.35M | 92.53M |
| Income Tax Expenses | 30.22M | 29.77M | 31.17M | 34.29M | 38.19M |
| Earnings from Continuing Operations | 17.56 | 34.83 | 34.81 | 42.06 | 54.34 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -567.00K | -707.00K | 82.00K | -30.00K | -- |
| Net Income | 16.99M | 34.12M | 34.90M | 42.03M | 54.34M |
| EBIT | 41.82M | 56.20M | 57.32M | 66.32M | 82.33M |
| EBITDA | 69.82M | 79.85M | 77.04M | 80.86M | 95.79M |
| EPS Basic | 0.89 | 1.80 | 1.83 | 2.20 | 2.84 |
| Normalized Basic EPS | 1.56 | 2.10 | 2.17 | 2.49 | 3.02 |
| EPS Diluted | 0.88 | 1.79 | 1.81 | 2.18 | 2.83 |
| Normalized Diluted EPS | 1.55 | 2.09 | 2.16 | 2.49 | 3.01 |
| Average Basic Shares Outstanding | 74.96M | 75.74M | 76.30M | 76.43M | 76.58M |
| Average Diluted Shares Outstanding | 75.02M | 75.81M | 76.43M | 76.65M | 76.80M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |